Cargando…

Estimation of minimal clinically important change of the Japanese version of EQ-5D in patients with chronic noncancer pain: a retrospective research using real-world data

BACKGROUND: Quality of life (QoL) is routinely assessed and evaluated in medical research. However, in Japan, there is a lack of solid cutoff criteria for evaluating QoL improvement in chronic noncancer pain management. The present study was conducted to identify the minimal clinically important cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshizawa, Kazutake, Kobayashi, Hisanori, Fujie, Motoko, Ogawa, Yoshimasa, Yajima, Tsutomu, Kawai, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773997/ https://www.ncbi.nlm.nih.gov/pubmed/26931101 http://dx.doi.org/10.1186/s12955-016-0438-2

Ejemplares similares

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting
por: Nakagawa, Ryoko, et al.
Publicado: (2017)

Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials
por: Nakayama, Masahiko, et al.
Publicado: (2016)

Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin
por: Nakayama, Masahiko, et al.
Publicado: (2015)

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild‐to‐moderate Alzheimer's disease: a Bayesian network meta‐analysis
por: Kobayashi, Hisanori, et al.
Publicado: (2015)

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
por: Nakagawa, Ryoko, et al.
Publicado: (2015)

Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan
por: Nakayama, Masahiko, et al.
Publicado: (2018)

The importance to update the guidelines for the use of genetic testing in noncancer patients in Brazil
por: Lajus, Tirzah Braz Petta
Publicado: (2015)

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
por: Pickard, A Simon, et al.
Publicado: (2007)

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
por: Pickard, A Simon, et al.
Publicado: (2010)

Linguistic and Psychometric Validation of the Cognition Bolt-On Version of the Japanese EQ-5D-5L for the Elderly
por: Igarashi, Ataru, et al.
Publicado: (2023)

Association of code status discussion with invasive procedures among advanced-stage cancer and noncancer patients
por: Sasaki, Akinori, et al.
Publicado: (2017)

Association between locomotive syndrome and the Japanese version of the EQ-5D-5L in middle-aged and elderly people in Japan
por: Tanaka, Satoshi, et al.
Publicado: (2020)

Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
por: Wille, Nora, et al.
Publicado: (2010)

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients
por: Morishige, Ryuji, et al.
Publicado: (2016)

Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: Incidence, mortality and clinical characterization
por: Yoshizawa, Kazutake, et al.
Publicado: (2014)

The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs
por: Korbecki, Jan, et al.
Publicado: (2022)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity
por: Shiroiwa, T., et al.
Publicado: (2019)

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
por: Herdman, M., et al.
Publicado: (2011)

Current assessment practices for noncancer end points.
por: Shoaf, C R
Publicado: (1991)

Risk characterization framework for noncancer end points.
por: Pierson, T K, et al.
Publicado: (1991)

Shared Decision-Making in Patients With Prostate Cancer in Japan: Patient Preferences Versus Physician Perceptions
por: Schaede, Ulrike, et al.
Publicado: (2017)

Validation of the Tinnitus Acceptance Questionnaire: Japanese Version
por: Takabatake, So, et al.
Publicado: (2022)

Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies
por: Saito, Yoji, et al.
Publicado: (2018)

European clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain
por: Häuser, Winfried, et al.
Publicado: (2021)

The Potential Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Cardiovascular System, Respiratory System and Skin
por: Korbecki, Jan, et al.
Publicado: (2022)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study
por: Hu, Xin, et al.
Publicado: (2020)

Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
por: Lawson, Erin F., et al.
Publicado: (2010)

Opioid Pharmacotherapy for Chronic Noncancer Pain: The American Experience
por: Chapman, C. Richard
Publicado: (2013)

Cancer and Noncancer Mortality Among American Seafood Workers
por: Johnson, Eric S., et al.
Publicado: (2011)

Monitoring Pharmacological Treatment in Patients With Chronic Noncancer Pain
por: Vargas-Schaffer, Grisell, et al.
Publicado: (2021)

Performance of the EQ-5D-Y Interviewer Administered Version in Young Children
por: Amien, Razia, et al.
Publicado: (2022)

Validity and reliability of Spanish version of the EQ-i: YV[S] in Colombian children and youth
por: Navarro-Roldán, Claudia P., et al.
Publicado: (2023)

EQ-5D-Y Population Norms for Japanese Children and Adolescents
por: Shiroiwa, Takeru, et al.
Publicado: (2021)

Reliability and validity of the Japanese version of the Ocular pain assessment survey (OPAS-J)
por: Yamanishi, Ryutaro, et al.
Publicado: (2023)

Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease
por: Bae, Eunmi, et al.
Publicado: (2020)

The minimal important change for the EQ VAS based on the SF-36 health transition item: observations from 25772 spine surgery procedures
por: Joelson, Anders, et al.
Publicado: (2022)

The three-factor structure of the Autism-Spectrum Quotient Japanese version in pregnant women
por: Zain, Ekachaeryanti, et al.
Publicado: (2023)

Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness
por: Lin, D-Yin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_965c5km19qnb25idvdermkp0pn